There is a significant opportunity to disrupt the current interventional cardiology market with a new technology and treatment that may impact the treatment of heart attack and its prevention. There has been a lack of innovation in recent years in this market, and the introduction of therapies that are alternatives to implanted devices may overcome some of the limitations of today’s technologies. In combination with imaging technologies cryotherapy may finally open up the possibility of applying therapy to prevent future coronary events by locating areas of inflammation that could be treated to prevent plaque rupture leading to heart attack 

CLEAR AND PROVEN PATH TO COMMERCIALIZATION

  • Avoids use of implants and well documented problems / smoother regulatory path.
  • Experienced team.
  • Strong IP with worldwide patent protection for use of cryoenergy for treatment of inflamed plaque.

LARGE MARKET OPPORTUNITY

  • Current 1billion for heart attack treatment.
  • Medium term market potential of €5billion for heart attack prevention working with strategic partner to enable image guidance to target therapy.
 

Update

CryoTherapeutics closes new series B financing round at €7 million

Find out more